Literature DB >> 20309940

A potentially functional polymorphism in the promoter region of miR-34b/c is associated with an increased risk for primary hepatocellular carcinoma.

Yan Xu1, Li Liu, Jibin Liu, Yixin Zhang, Jian Zhu, Jianguo Chen, Sheng Liu, Zheng Liu, Haibin Shi, Hongbing Shen, Zhibin Hu.   

Abstract

The miR-34 family members are direct transcriptional targets of tumor suppressor p53, and loss of miR-34 function can impair p53-mediated cell cycle arrest and apoptosis. A potentially functional SNP rs4938723 (T > C) was found in the promoter region of pri-miR-34b/c (423 bp from the transcription start site), located in the CpG island and might affect transcription factor GATA binding and therefore pri-miR-34b/c expression. In our study, we hypothesized that SNPs miR-34b/c rs4938723 and TP53 Arg72Pro may independently or jointly contribute to primary hepatocellular carcinoma (HCC) susceptibility. We then genotyped the 2 SNPs in a case-control study of 501 patients with primary HCC and 548 cancer-free controls in a Chinese population. We observed that the variant genotypes of miR-34b/c rs4938723 were associated with significantly increased HCC risks compared with the wild-type TT genotype (adjusted OR = 1.37, 95% CI =1.06-1.78 for TC; OR = 1.53, 95% CI = 1.02-2.31 for CC and OR = 1.40, 95% CI = 1.10-1.80 for TC/CC). Furthermore, we found a significant interaction between alcohol drinking and SNP rs4938723 on HCC risk (p = 0.05 for multiplicative and p = 0.01 for additive interaction). However, we did not find any main effect of TP53 Arg72Pro on HCC risk in this population. These findings indicate that the potentially functional SNP rs4938723 in the promoter region of pri-miR-34b/c may contribute to the susceptibility of HCC in this Chinese population.
Copyright © 2010 UICC.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20309940     DOI: 10.1002/ijc.25342

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  75 in total

Review 1.  Epigenetics of hepatocellular carcinoma: role of microRNA.

Authors:  Sharad Khare; Qiong Zhang; Jamal A Ibdah
Journal:  World J Gastroenterol       Date:  2013-09-07       Impact factor: 5.742

2.  Identification of miR-423 and miR-499 polymorphisms on affecting the risk of hepatocellular carcinoma in a large-scale population.

Authors:  Yanyun Ma; Rui Wang; Jun Zhang; Wenshuai Li; Chunfang Gao; Jie Liu; Jiucun Wang
Journal:  Genet Test Mol Biomarkers       Date:  2014-05-22

Review 3.  Diagnostic and therapeutic application of noncoding RNAs for hepatocellular carcinoma.

Authors:  Chikako Shibata; Motoyuki Otsuka; Takahiro Kishikawa; Motoko Ohno; Takeshi Yoshikawa; Akemi Takata; Kazuhiko Koike
Journal:  World J Hepatol       Date:  2015-01-27

4.  pri-miR-34b/c rs4938723 polymorphism is associated with hepatocellular carcinoma risk: a case-control study in a Chinese population.

Authors:  Chun-Jia Liu; Xue-Wei Ma; Xue-Jun Zhang; Shi-Qiang Shen
Journal:  Int J Mol Epidemiol Genet       Date:  2017-02-15

Review 5.  Noncoding RNA as therapeutic targets for hepatocellular carcinoma.

Authors:  Joseph George; Tushar Patel
Journal:  Semin Liver Dis       Date:  2015-01-29       Impact factor: 6.115

6.  Interactions of miR-34b/c and TP-53 polymorphisms on the risk of nasopharyngeal carcinoma.

Authors:  Lijuan Li; Jian Wu; Xiutian Sima; Peng Bai; Wei Deng; Xueke Deng; Lin Zhang; Linbo Gao
Journal:  Tumour Biol       Date:  2013-03-17

Review 7.  Genetic risk markers for hepatocellular carcinoma in patients with alcoholic liver disease.

Authors:  Pierre Nahon; Angela Sutton; Marianne Ziol; Jessica Zucman-Rossi; Jean-Claude Trinchet; Nathalie Ganne-Carrié
Journal:  Hepat Oncol       Date:  2015-01-12

8.  The association between polymorphism of P53 Codon72 Arg/Pro and hepatocellular carcinoma susceptibility: evidence from a meta-analysis of 15 studies with 3,704 cases.

Authors:  Surong Hu; Lianying Zhao; Jingting Yang; Miao Hu
Journal:  Tumour Biol       Date:  2013-12-11

9.  Combined analysis of pri-miR-34b/c rs4938723 and TP53 Arg72Pro with cervical cancer risk.

Authors:  Fang Yuan; Ruifen Sun; Peng Chen; Yundan Liang; Shanshan Ni; Yi Quan; Juan Huang; Lin Zhang; Linbo Gao
Journal:  Tumour Biol       Date:  2015-11-30

10.  Genetic variations at microRNA and processing genes and risk of oral cancer.

Authors:  Roshni Roy; Navonil De Sarkar; Sandip Ghose; Ranjan R Paul; Mousumi Pal; Chandrika Bhattacharya; Shweta K Roy Chowdhury; Saurabh Ghosh; Bidyut Roy
Journal:  Tumour Biol       Date:  2013-12-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.